Milestone Scientific Schedules Second Quarter 2017 Earnings Conference Call
LIVINGSTON, NJ -- (Marketwired) -- 08/10/17 -- Milestone Scientific Inc. (NYSE MKT: MLSS) (NYSE American: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that it will host a conference call at 8:00 AM Eastern Time on Tuesday, August 15, 2017 to discuss the Company's financial results for the second quarter ended June 30, 2017, as well as the Company's corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 866-564-2842 and entering the pass code 1085396 or on the company's website at www.milestonescientific.com. For those unable to participate at that time, a replay of the call will be archived on the company's website or can be accessed by dialing 888-203-1112 and entering the pass code 1085396. The replay will be available for 90 days.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
Contact:David Waldman or Natalya RudmanCrescendo Communications, LLCEmail: [email protected]: 212-671-1020
Source: Milestone Scientific, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Village Voyage: Where northern China’s countryside finds new rhythms
- UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share